Disulfiram repurposing combined with nutritional copper supplement as add-on to chemotherapy in recurrent glioblastoma (DIRECT): Study protocol for a randomized controlled trial [version 1; referees: 2 approved]

Background: Disulfiram (DSF) is a well-tolerated, inexpensive, generic drug that has been in use to treat alcoholism since the 1950s. There is now independent preclinical data that supports DSF as an anticancer agent, and experimental data suggest that copper may increase its anti-neoplastic propert...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Asgeir Store Jakola, Katja Werlenius, Munila Mudaisi, Sofia Hylin, Sara Kinhult, Jiri Bartek Jr., Øyvind Salvesen, Sven Magnus Carlsen, Michael Strandéus, Magnus Lindskog, David Löfgren, Bertil Rydenhag, Louise Carstam, Sasha Gulati, Ole Solheim, Jiri Bartek, Tora Solheim
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: F1000 Research Ltd 2018-11-01
Saila:F1000Research
Sarrera elektronikoa:https://f1000research.com/articles/7-1797/v1
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak